Related by context. Frequent words. (Click for all words.) 63 oncolytic virus therapies 61 Aerosurf 60 liposomal formulation 59 PDE4 inhibitor 59 treat male hypogonadism 59 Lipid Polymer Micelle LPM 59 Factor VIIa 58 MKC# 58 T# R# 58 S# +# mins #.#secs 58 2 methoxyestradiol 58 Nanobody 58 SAR# [002] 58 StromaCel Inc. 57 * Azixa 57 Microspheres 57 Nuclear Pharm Assist 57 Receives Orphan Drug Designation 57 polymerase inhibitor 57 TLR9 agonist 57 Initiates Phase II 56 immunotherapeutic agent 56 produces Chrysler Jeep 56 humanized anti 56 Meets Primary Endpoint 56 +# mins #.#secs N4 56 catheter occlusion 56 E1 INT TM 56 Prism Pharmaceuticals 56 humanized antibody 56 #.#L DOHC 56 PSMA ADC 55 Receptor Antagonist 55 Traficet EN 55 #-# Lexus IS# 55 TELINTRA 55 novel orally administered 55 shaped Genmab 55 EP# [003] 55 HuMax CD4 55 vascular disrupting agent 55 receptor agonists 55 Commences Phase 55 +1 min #.#secs 55 ATL/TV# 55 Degarelix 55 Back Guar 55 TLR9 agonists 55 anticancer compound 55 Recombinant Human 55 Xanafide 54 Exhaust Gas Recirculation 54 immatics 54 Inhalation Solution 54 Inhalation Powder 54 Methylnaltrexone 54 therapeutic monoclonal antibodies 54 peripherally acting 54 KUKA Roboter GmbH 54 DB# [003] 54 Avila Therapeutics 54 Therapeutic Competitors Report 54 8 CYL 54 receptor agonist 54 double overhead camshaft 54 Metallic Paint 54 COUPE 54 Roche SIX RO 53 HCV protease inhibitor 53 World Favorite Ketchup 53 B lymphocyte stimulator 53 agonist LABA 53 G GLASS 53 Locteron ® 53 PRT# 53 Onconase 53 subcutaneous formulation 53 multi kinase inhibitor 53 PRO# [003] 53 By Naoise O 53 Dapagliflozin 53 ISOCOUNTRY3 53 pancreatic enzyme replacement 53 Phase Ib study 53 RELEASE ACCORDING TO 53 TRC# 53 Panzem R 53 Announces FDA Clearance 53 Diabetic Neuropathy 53 GlycoPEG GCSF 53 Vaccinex 53 Carfilzomib 53 Initiate Phase 53 ECD UNI SOLAR 53 DDP# 53 DP b# 53 ATL# [001] 53 HuMax HepC TM 52 Phase Ib II 52 ONX 52 Ocrelizumab